Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09YVZ
|
||||
Former ID |
DNC010423
|
||||
Drug Name |
Benzaldehyde O-4-(heptyloxy)phenylcarbamoyl oxime
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530604] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H26N2O3
|
||||
Canonical SMILES |
CCCCCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CC=CC=C2
|
||||
InChI |
1S/C21H26N2O3/c1-2-3-4-5-9-16-25-20-14-12-19(13-15-20)23-21(24)26-22-17-18-10-7-6-8-11-18/h6-8,10-15,17H,2-5,9,16H2,1H3,(H,23,24)/b22-17+
|
||||
InChIKey |
QGTJCMKYCHZBTK-OQKWZONESA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.